OTC : ARDS

Aridis Pharmaceuticals, Inc. — Earnings Estimates

$0.0001 USD

$0 (0.0%)

Volume
40.1K
Average Volume
15.13K
Market Capitalization
$4.46K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$0.05
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.32

Annual earnings financials

ARDS financial data with annual/quarterly toggle

ARDS GAAP EPS - Annual & Quarterly

ARDS Sales Revenue - Annual & Quarterly

ARDS Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ARDS Estimated and Actual Revenue by Quarter
ARDS Estimated and Actual EPS by Quarter
ARDS Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2029-09-30 1 -59999 -59999 -59999 -59999 -59999 -59999
2029-06-30 1 -300K -300K -300K -300K -300K -300K
2029-03-30 1 -59999 -59999 -59999 -59999 -59999 -59999
2028-12-30 1 -300K -300K -300K -300K -300K -300K
2028-09-30 1 -300K -300K -300K -300K -300K -300K
2028-06-30 1 -300K -300K -300K -300K -300K -300K
ARDS Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2029-09-30 1 -748.58K -748.58K -748.58K 944.78K 944.78K 944.78K
2029-06-30 1 -3.74M -3.74M -3.74M 4.72M 4.72M 4.72M
2029-03-30 1 -748.58K -748.58K -748.58K 944.78K 944.78K 944.78K
2028-12-30 1 -3.74M -3.74M -3.74M 4.72M 4.72M 4.72M
2028-09-30 1 -3.74M -3.74M -3.74M 4.72M 4.72M 4.72M
2028-06-30 1 -3.74M -3.74M -3.74M 4.72M 4.72M 4.72M
ARDS Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2029-09-30 1 300K 300K 300K 1 -0.02 -0.02 -0.02
2029-06-30 1 1.5M 1.5M 1.5M 1 -0.1 -0.1 -0.1
2029-03-30 1 300K 300K 300K 1 -0.02 -0.02 -0.02
2028-12-30 1 1.5M 1.5M 1.5M 1 -0.1 -0.1 -0.1
2028-09-30 1 1.5M 1.5M 1.5M 1 -0.1 -0.1 -0.1
2028-06-30 1 1.5M 1.5M 1.5M 1 -0.1 -0.1 -0.1